These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 31433948)

  • 1. Intercostal Herniation of Pleural Fluid.
    Newman TA; Brady AK; Shriki JE; Takasugi JE; Adamson R
    Am J Respir Crit Care Med; 2020 Jan; 201(2):e5. PubMed ID: 31433948
    [No Abstract]   [Full Text] [Related]  

  • 2. Nodular histiocytic hyperplasia: Is this a cause of dasatinib-pleural effusion?
    Hamada S; Hayashi E; Tsukino M
    Arch Bronconeumol; 2017 Apr; 53(4):212-213. PubMed ID: 27825730
    [No Abstract]   [Full Text] [Related]  

  • 3. Pleural Effusion in Dasatinib-Treated Patients With Chronic Myeloid Leukemia in Chronic Phase: Identification and Management.
    Cortes JE; Jimenez CA; Mauro MJ; Geyer A; Pinilla-Ibarz J; Smith BD
    Clin Lymphoma Myeloma Leuk; 2017 Feb; 17(2):78-82. PubMed ID: 28082112
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dasatinib-induced chylothorax: report of a case and review of the literature.
    Chen B; Wu Z; Wang Q; Li W; Cheng D
    Invest New Drugs; 2020 Oct; 38(5):1627-1632. PubMed ID: 32248338
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A 68-Year-Old Man With Chronic Myelogenous Leukemia and a Large Unilateral Pleural Effusion.
    Alter A; Chaisson N; Mukherjee S; Gildea T
    Chest; 2018 Feb; 153(2):e33-e36. PubMed ID: 29406237
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pleural effusion in patients with chronic myelogenous leukemia treated with dasatinib after imatinib failure.
    Quintás-Cardama A; Kantarjian H; O'brien S; Borthakur G; Bruzzi J; Munden R; Cortes J
    J Clin Oncol; 2007 Sep; 25(25):3908-14. PubMed ID: 17761974
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Severe dyspnoea in a patient with chronic myelogenous leukaemia on a tyrosine kinase inhibitor.
    Ustun C; Randall N; Podgaetz E; Amin K; Dincer HE
    Thorax; 2015 Jul; 70(7):701-4. PubMed ID: 25935168
    [No Abstract]   [Full Text] [Related]  

  • 8. Dasatinib in chronic myelogenous leukemia.
    Kathula SK
    N Engl J Med; 2006 Sep; 355(10):1062; author reply 1063-4. PubMed ID: 16957155
    [No Abstract]   [Full Text] [Related]  

  • 9. Successful Control of Dasatinib-related Chylothorax by the Japanese Herbal Medicine "Goreisan".
    Sasaki H; Kimizuka Y; Ogata H; Okada Y; Ota S; Sano T; Watanabe C; Maki Y; Yamamoto T; Tagami Y; Miyata J; Hayashi N; Fujikura Y; Kawana A
    Intern Med; 2019 Nov; 58(21):3139-3141. PubMed ID: 31292394
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unusual extramedullary relapses under imatinib mesylate treatment in chronic myeloid leukemia.
    Beyazit Y; Aksu S; Kekilli M; Haznedaroglu IC; Kilickap S; Goker H
    Am J Hematol; 2005 May; 79(1):79-80. PubMed ID: 15849758
    [No Abstract]   [Full Text] [Related]  

  • 11. Chylothorax: complication attributed to dasatinib use.
    Al-Abcha A; Iftikhar MH; Abu Rous F; Laird-Fick H
    BMJ Case Rep; 2019 Dec; 12(12):. PubMed ID: 31848139
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of pleural effusion with an early molecular response in patients with newly diagnosed chronic-phase chronic myeloid leukemia receiving dasatinib: Results of a D-First study.
    Hagihara M; Iriyama N; Yoshida C; Wakita H; Chiba S; Okamoto S; Kawakami K; Takezako N; Kumagai T; Inokuchi K; Ohyashiki K; Taguchi J; Yano S; Igarashi T; Kouzai Y; Morita S; Sakamoto J; Sakamaki H
    Oncol Rep; 2016 Nov; 36(5):2976-2982. PubMed ID: 27665844
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A Case of Drug-Induced Organizing Pneumonia Caused by Dasatinib].
    Sato M; Watanabe S; Aoki N; Asakawa K; Moriyama H; Oshima Y; Koya T; Okazuka K; Kikuchi T
    Gan To Kagaku Ryoho; 2018 May; 45(5):851-854. PubMed ID: 30026450
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug-induced chylothorax as a rare pleural complication in dasatinib therapy for chronic myeloid leukaemia.
    Ng IK; Ruparel M; Chan EH; Khoo KL
    J R Coll Physicians Edinb; 2024 Mar; 54(1):44-47. PubMed ID: 38486345
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pleural-pericardic effusion as uncommon complication in CML patients treated with Imatinib.
    Breccia M; D'Elia GM; D'Andrea M; Latagliata R; Alimena G
    Eur J Haematol; 2005 Jan; 74(1):89-90. PubMed ID: 15613116
    [No Abstract]   [Full Text] [Related]  

  • 16. Is dasatinib-related pulmonary hypertension a clinical concern?
    Szmit S
    Future Oncol; 2015 Sep; 11(18):2491-4. PubMed ID: 26278893
    [No Abstract]   [Full Text] [Related]  

  • 17. Lymphocytosis after treatment with dasatinib in chronic myeloid leukemia: Effects on response and toxicity.
    Schiffer CA; Cortes JE; Hochhaus A; Saglio G; le Coutre P; Porkka K; Mustjoki S; Mohamed H; Shah NP
    Cancer; 2016 May; 122(9):1398-407. PubMed ID: 26998677
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human herpesvirus 8-unrelated primary effusion lymphoma-like lymphoma following tyrosine kinase inhibitor treatment for chronic myelogenous leukemia.
    Kojima M; Nakamura N; Amaki J; Numata H; Miyaoka M; Motoori T; Matsumoto K; Ando K
    J Clin Exp Hematop; 2017; 57(2):69-73. PubMed ID: 29021516
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic Pitfalls of Chylothorax After Dasatinib Treatment of Chronic Myeloid Leukemia.
    Kelly RL; Bae JY; D'Annunzio S; Montanari F
    Am J Case Rep; 2022 Nov; 23():e938319. PubMed ID: 36444127
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dasatinib increases endothelial permeability leading to pleural effusion.
    Phan C; Jutant EM; Tu L; Thuillet R; Seferian A; Montani D; Huertas A; Bezu JV; Breijer F; Vonk Noordegraaf A; Humbert M; Aman J; Guignabert C
    Eur Respir J; 2018 Jan; 51(1):. PubMed ID: 29348177
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.